Becton Dickinson And Company  (BDX)
Other Ticker:  

Becton Dickinson's



BDX Sales vs. its Competitors Q3 2022

Comparing the results to its competitors, Becton Dickinson reported Total Revenue decrease in the 3 quarter 2022 year on year by -17.78 %, faster than overall decrease of Becton Dickinson's competitors by -22.64 %, recorded in the same quarter.

List of BDX Competitors

With net margin of 6.77 % company achieved higher profitability than its competitors.

More on BDX Margin Comparisons

Revenue Growth Comparisons

Net Income Comparison

Becton Dickinson And Company Net Income in the 3 quarter 2022 grew year on year by 8.75 %, while most of its competitors have experienced contraction in net income by -18.94 %.

<<  More on BDX Income Comparisons

Becton Dickinson's Comment on Competitors and Industry Peers

BD operates in the increasingly complex and challenging medical technology marketplace. Technological advances and scientific discoveries have accelerated the pace of change in medical technology, the regulatory environment of medical products is becoming more complex and vigorous, and economic conditions have resulted in a challenging market. Companies of varying sizes compete in the global medical technology field. Some are more specialized than BD with respect to particular markets, and some have greater financial resources than BD. New companies have entered the field, particularly in the areas of molecular diagnostics, safety-engineered devices and in the life sciences, and established companies have diversified their business activities into the medical technology area.

Other firms engaged in the distribution of medical technology products have become manufacturers of medical devices and instruments as well. Acquisitions and collaborations by and among companies seeking a competitive advantage also affect the competitive environment. In addition, the entry into the market of manufacturers located in China and other low-cost manufacturing locations are creating increased pricing pressures, particularly in developing markets. Some competitors have also established manufacturing sites or have contracted with suppliers located in these countries as a means to lower their costs.
BD competes in this evolving marketplace on the basis of many factors, including price, quality, innovation, service, reputation, distribution and promotion.

The impact of these factors on BD’s competitive position varies among BD’s various product offerings. In order to remain competitive in the industries in which it operates, BD continues to make investments in research and development, quality management, quality improvement, product innovation and productivity improvement in support of its core strategy — to increase revenue growth by focusing on products that deliver greater benefits to patients, healthcare workers and researchers.


Overall company Market Share Q3 2022

despite revenue deterioration, Becton Dickinson inceased its market share in this segment.

company inceased its market share in this segment to approximate 2.42 %.

<<  More on BDX Market Share.
*Market share is calculated based on total revenue.

BDX's vs. Competition, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

(in millions of $)
(in millions of $)
(in millions of $)
Becton Dickinson And Company BDX 71,228.12 18,870.00 1,779.00 72,000
Amerisourcebergen Corp ABC 36,093 236,325.28 1,804.31 22,000
Abbott Laboratories ABT 188,570 45,030.00 7,889.00 107,000
Cardinal Health Inc CAH 22,053 186,999.00 -1,093.00 48,000
Danaher Corporation DHR 200,440 31,250.00 6,765.00 60,000
Johnson and Johnson JNJ 471,582 95,245.00 19,139.00 132,200
Mckesson Corporation MCK 54,994 272,027.00 2,220.00 80,000
Medtronic Plc MDT 103,616 30,808.00 4,342.00 90,000
Thermo Fisher Scientific Inc TMO 226,044 39,982.00 6,889.00 75,000
Baxter International Inc BAXNYSE 0 14,740.00 -2,364.00 0
Helen Of Troy Limited HELE 2,414 2,073.87 137.90 1,610
Honeywell International Inc HON 145,228 34,937.00 5,388.00 105,500
3m Company MMM 71,820 34,762.00 6,588.00 95,000
Adm Tronics Unlimited Inc ADMT 5 3.70 -1.26 21
Codexis inc CDXS 366 132.72 -31.18 106
Dupont De Nemours Inc DD 34,878 14,184.00 1,905.00 34,250
SUBTOTAL 1,629,331.69 1,057,369.56 61,356.78 922,687

Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

EXNT's Profile

Stock Price

EXNT's Financials

Business Description


Charts & Quotes

EXNT's News


EXNT's Competitors

Customers & Markets

Economic Indicators

EXNT's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries




At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071